Related references
Note: Only part of the references are listed.Retinopathy of prematurity: A review of pathophysiology and signaling pathways
Mariza Fevereiro-Martins et al.
SURVEY OF OPHTHALMOLOGY (2023)
One-stop assembly of adherent 3D retinal organoids from hiPSCs based on 3D-printed derived PDMS microwell platform
Xihao Sun et al.
BIOFABRICATION (2023)
The role of anti-vascular endothelial growth factor in treatment of retinopathy of prematurity-a current review
Shing Chuen Chow et al.
EYE (2022)
Anti-angiogenic properties of rapamycin on human retinal pericytes in an in vitro model of neovascular AMD via inhibition of the mTOR pathway
Ben Asani et al.
BMC OPHTHALMOLOGY (2022)
Application of Bioprinting in Ophthalmology
Yanfang Wang et al.
INTERNATIONAL JOURNAL OF BIOPRINTING (2022)
A Bioprinted Bruch's Membrane for Modeling Smoke-Induced Retinal Pigment Epithelium Degeneration via Hybrid Membrane Printing Technology
Jongmin Kim et al.
ADVANCED HEALTHCARE MATERIALS (2022)
Changes in components of the neurovascular unit in the retina in a rat model of retinopathy of prematurity
Ayuki Nakano et al.
CELL AND TISSUE RESEARCH (2020)
mTOR at the nexus of nutrition, growth, ageing and disease
Grace Y. Liu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Metabolic pathways in context:mTORsignalling in the retina and optic nerve - A review
Anthony Yao et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)
Update on Anti-Vascular Endothelial Growth Factor Safety for Retinopathy of Prematurity
Ana Bety Enriquez et al.
ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY (2020)
Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity
Ayuki Nakano et al.
EXPERIMENTAL EYE RESEARCH (2018)
Retinopathy of prematurity: a review of risk factors and their clinical significance
Sang Jin Kim et al.
SURVEY OF OPHTHALMOLOGY (2018)
Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats
Ayuki Nakano et al.
EXPERIMENTAL EYE RESEARCH (2016)
Anti-angiogenic Effects of Mammalian Target of Rapamycin Inhibitors in a Mouse Model of Oxygen-Induced Retinopathy
Rina Yagasaki et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
Effects of mTOR inhibition on normal retinal vascular development in the mouse
Rina Yagasaki et al.
EXPERIMENTAL EYE RESEARCH (2014)
Rapamycin prevents N-methyl-D-aspartate-induced retinal damage through an ERK-dependent mechanism in rats
Atsuko Ichikawa et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Autophagy promotes survival of retinal ganglion cells after optic nerve axotomy in mice
N. Rodriguez-Muela et al.
CELL DEATH AND DIFFERENTIATION (2012)
Role of mTOR in neuroprotection and axon regeneration after inflammatory stimulation
Marco Leibinger et al.
NEUROBIOLOGY OF DISEASE (2012)
Hyperoxia Therapy of Pre-Proliferative Ischemic Retinopathy in a Mouse Model
Wenbo Zhang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A164-Driven Angiogenesis, in Part by Blocking S6Kinase
Qi Xue et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro
A. Stahl et al.
FEBS LETTERS (2008)
Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: Relevance to plus disease
M. Elizabeth Hartnett et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)